Opendata, web and dolomites

SUPAIR Spectroscopy

SUPAIR Spectroscopy: Single-Use Process Analytical Infrared Spectroscopy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUPAIR Spectroscopy project word cloud

Explore the words cloud of the SUPAIR Spectroscopy project. It provides you a very rough idea of what is the project "SUPAIR Spectroscopy" about.

infrared    fourier    cell    commercial    savings    monitored    patent    150    500    technologies    consecutive    expensive    reflectance    spectroscopy    read    time    efficiency    silicon    award    team    techniques    optical    200    consumption    flow    crystal    sensors    valley    requiring    pat    water    transform    company    mir    business    first    pending    quality    feasibility    roadmap    cultivating    medical    spectrometer    carry    attenuated    sub    analytical    costing    innovation    performed    mammalian    cells    total    sterilization    compact    market    merits    merck    half    probes    direct    distributors    online    promoted    energy    poised    offers    solution    flexible    solutions    exist    eliminates    biopharma    reactors    sme    atr    streams    mid    billion    usually    render    automated    sales    biologic    optimal    awarded    price    drugs    complete    customers    competing    ftir    accelerator    affordable    monitoring    b2b    companies    irubis    bioreactors    biopharmaceutical    300    size    revenue    reused    impressive    model    industry    scholarship    single    2025   

Project "SUPAIR Spectroscopy" data sheet

The following table provides information about the project.

Coordinator
IRUBIS GMBH 

Organization address
address: SCHILLERSTRASSE 40 B
city: MUNCHEN
postcode: 80336
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://irubis.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IRUBIS GMBH DE (MUNCHEN) coordinator 50˙000.00

Map

 Project objective

The biopharmaceutical industry is poised to reach an impressive market size of more than €300 billion by 2025. The production of biologic drugs is usually performed by cultivating mammalian cells within bioreactors. Those reactors are increasingly being monitored online by means of Process Analytical Technologies (PAT). However state-of-the-art techniques render both sub-optimal product quality and product efficiency. A complete mid-infrared (MIR) spectroscopy system using online Attenuated Total Reflectance (ATR) probes is highly expensive costing around €200,000, €20,000 only for the probes that are not robust enough, requiring consecutive sterilization to be reused (raising water and energy consumption). IRUBIS GmbH team goal is to make online monitoring of (single-use) bioreactors affordable. IRUBIS innovation comprises a single-use patent-pending silicon ATR crystal integrated in a single-use ATR Flow Cell which is read out by a compact Fourier Transform Infrared (FTIR) Spectrometer. IRUBIS Analytical Technology offers a system that will allow for the first time real-time process control (online) in single-use bioreactors. This means a flexible, highly automated system solution that costs half the price of the competing solutions. Furthermore, it eliminates sterilization requirements allowing for important energy savings. IRUBIS has been awarded an accelerator program promoted by Merck; Company recent merits also include the Medical valley award (€500,000) and the Exist scholarship (€150,000). Our business model will be based in two revenue streams: B2B direct sales of developed IRUBIS optical sensors to biopharma companies and sales through partnerships with distributors. The feasibility study we will carry out under this SME Phase 1 project, will define the technical, market and commercial roadmap allowing to offer customers a higher value product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPAIR SPECTROSCOPY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPAIR SPECTROSCOPY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More  

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More